Browse Jaunts
Help
Social
Legal

Tag #curesjia

NextGen 2024: Weaning meds when disease is controlled Session Part 2 15 slides
Jaunt
Summary:

Presentation from Dr. Fatma Dedeoglu: Weaning Therapy
@SJIA_Foundation
NextGen 2024: Weaning meds when disease is controlled Session Part 1 17 slides
Jaunt
Summary:

Presentation from Dr. Bas Vastert: Biomarker-Guided Treatment-And-Stop_Strategy for Recombinat IL-1Receptor Antagonist (anakinra) in systemic Juvenile Idiopathic Arthritis
@SJIA_Foundation
NextGen 2024: Genetics in SJIA Session Part 3 20 slides
Jaunt
Summary:

Presentation from Dr. Michael Ombrello: What is the role of HLA DRB1*15 in Still's disease
@SJIA_Foundation
NextGen 2024: Genetics in SJIA Session Part 2 19 slides
Jaunt
Summary:

Presentation from Dr. Mariana Marques: Recent discovery in genomics of SJIA
@SJIA_Foundation
NextGen 2024: Genetics in SJIA Session Part 1 12 slides
Jaunt
Summary:

Presentation from Dr. Randy Cron: Clinical Utility of Genetics in systemic JIA
@SJIA_Foundation
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2 11 slides
Jaunt
Summary:

Presentation from Dr. Lauren Henderson: recognizing and Treating Lung Disease in Systemic Juvenile idiophatic Arthritis
@SJIA_Foundation
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1 7 slides
Jaunt
Summary:

Presentation from Dr. Claudia Bracaglia: Monitoring and Treating Lung Disease in Still's Disease
@SJIA_Foundation
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5 5 slides
Jaunt
Summary:

Presentation from Dr. Grant Schulert: Criteria to consider BMT

@SJIA_Foundation
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4 14 slides
Jaunt
Summary:

Presentaton from Dr. Juliana Silva: Long Term outcomes of Allogeneic HSCT for severe, refractory Juvenile Idiopathic Arthritis
@SJIA_Foundation
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3 10 slides
Jaunt
Summary:

Presentation from Dr. Jim Connelly: Immune Reconstitution after Bone Marrow Transplant
@SJIA_Foundation
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 2 33 slides
Jaunt
Summary:

Presentation from Dr. Rebecca Marsh: BMT: How does it work and when it can be considered?
@SJIA_Foundation
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1 6 slides
Jaunt
Summary:

Patient perspective about BMT in SJIA: Presentation from Luciana Pereira
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 8 10 slides
Jaunt
Summary:

International Perspective: Presentation from dr Bruno Fautrel: Treating Refractory Adult Still's Patients
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 7 4 slides
Jaunt
Summary:

International Perspective: Presentation from Dr. Juan Manuel Mosquera, Spain: Refractory disease (Still’s +/- MAS)
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 6 13 slides
Jaunt
Summary:

International perspectives (China): Presentation from Dr. Caifeng Li
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 5 3 slides
Jaunt
Summary:

International perspectives (Brazil): Presentation from Dr. Maria Teresa Terreri
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 4 23 slides
Jaunt
Summary:

Presentation from Dr. Nadrendra Bagri: International perspectives (India)
@SJIA_Foundation
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 2 11 slides
Jaunt
Summary:

Presentation from Dr. Fabrizzio de Benedeti: Clinical Trials in Still's Disease (sJIA/AOSD)
@SJIA_Foundation
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1 11 slides
Jaunt
Summary:

Presentation from Dr. Alexei Grom: SJIA with relapsing MAS
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 3 21 slides
Jaunt
Summary:

Presentation from Dr. Ed Behrens: Treatment Paterns and Outcomes in Patients with Macrophage Activation Syndrome Secondary to Still's Disease Treated with Emapalumab
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 2 7 slides
Jaunt
Summary:

Presentation from Dr. Paul brogan: Systemic Juvenile Idiopathic Arthritis: resistant disease, UK experience
@SJIA_Foundation
NextGen 2024: Refractory SJIA & MAS Session Part 1 10 slides
Jaunt
Summary:

Presentation from Dr. Grant Schulert: The Changing face of SJIA.
@SJIA_Foundation
IL-18 testing in the diagnosis and management of Still’s disease: Game-changer or Red Herring? 13 slides
Jaunt
Summary:

Dr. Scott Canna did this presentation about IL-18 testing at NextGen 2024.
@SJIA_Foundation
Clinical significance of serum IL-18 levels for the diagnosis and monitoring of disease activity 40 slides
Jaunt
Summary:

Presentation from Dr. Masaki Shimizu for NextGen 2024. Dr. Shimizu was the Keynote Speaker and talked about his IL-18 lab work.

@SJIA_Foundation
BMT in SJIA patients 13 pages
Jaunt
Summary:

This paper discusses recent findings on hematopoietic stem cell transplantation (HSCT) in patients with refractory systemic juvenile idiopathic arthritis (SJIA) and associated lung disease. It encompasses insights from case studies, optimal timing for procedures, and the management of complications to improve patient outcomes. Long-term follow-ups post-HSCT show promising results, but highlight the need for more data to determine the best candidate profile.
@lucianapapaleo

BMT in SJIA patients
@lucianapapaleo
  • 2 months, 2 weeks ago
  • 211 views

We, and our third-party partners, use cookies, pixels, and other technologies ("cookies") to collect, record, and share information you provide, as well as information about your interactions with, our site for ad targeting, analytics, personalization, and site functionality purposes. By clicking Agree, you agree to the use of tracking technologies and acknowledge our privacy practices as described in our Privacy Notice.

Login

OR

Forgot password?

Don't have an account? Sign Up